The DOI matches its Crossref record; 526 of the 527 references it cites were found in a registry or an index; none of the 524 sources its claims cite is checked for support yet.
Autophagy and ALS: mechanistic insights and therapeutic implications
Open accessAbstract
: ALS: amyotrophic lateral sclerosis; Atg: autophagy-related; CHMP2B: charged multivesicular body protein 2B; DPR: dipeptide repeat; FTD: frontotemporal dementia; iPSC: induced pluripotent stem cell; LIR: LC3-interacting region; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MTOR: mechanistic target of rapamycin kinase; PINK1: PTEN induced kinase 1; RNP: ribonuclear protein; sALS: sporadic ALS; SPHK1: sphingosine kinase 1; TARDBP/TDP-43: TAR DNA binding protein; TBK1: TANK-binding kinase 1; TFEB: transcription factor EB; ULK: unc-51 like autophagy activating kinase; UPR: unfolded protein response; UPS: ubiquitin-proteasome system; VCP: valosin containing protein.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes mechanistic links between autophagy dysfunction and ALS, focusing on ALS-associated mutations in autophagy-related genes and cell type-specific regulation of autophagy. It argues that effective autophagy-based therapies will require targeting the pathway in specific cell types rather than indiscriminate induction.
Key findings
- ALS-related mutations affect multiple autophagy stages and factors, including SQSTM1, C9orf72, TBK1, UBQLN2, FUS, VCP, OPTN, and CHMP2B; these mutations impair selective autophagy, mitophagy, autophagosome maturation, or autophagic flux.
- Reported mutation frequencies include C9orf72 expansion in 23–47% of familial ALS/FTD and 4–21% of sporadic disease; TBK1 mutations in ~1% of familial or sporadic ALS; OPTN mutations in ~3% of familial and ~1% of sporadic ALS; VCP mutations in ~1–2% of familial ALS; and SQSTM1 mutations in ~1–3.5% of ALS-FTD cases.
- Autophagy regulation differs by cell type: neurons are insensitive or only mildly responsive to starvation and MTOR inhibition, whereas astrocytes, oligodendrocytes, Schwann cells, and skeletal muscle respond to these stimuli; neuronal autophagy can be induced by MTOR/AKT-independent compounds such as 10-NCP.
- Therapeutic implications are mixed: rapamycin can worsen disease in SOD1G93A ALS mice, lithium showed no clinical benefit in five ALS trials, and a phase II rapamycin trial in ALS began in 2018 with results not yet published.
Methods
- Narrative review of the autophagy pathway, ALS-associated autophagy-related mutations, disease models, and cell type-specific autophagy regulation.
- No primary experimental design, sample, or statistical analysis is reported; the paper synthesizes published cell, animal, iPSC, and human data.
- Main analysis is conceptual integration of mechanistic findings to identify therapeutic targets and remaining questions.
Limitations
- The authors state that mechanistic details of autophagy’s neuroprotective role, neuronal resistance to autophagy induction, neuron-specific effects of autophagy-impairing mutations, and non-cell autonomous contributions to ALS pathogenesis remain incompletely defined.
- The authors note that cell type-specific autophagy regulation is insufficiently explored, that cell and animal models may not faithfully reproduce human autophagy regulation, and that LC3-II accumulation cannot distinguish true autophagy induction from late-stage inhibition.
- Evident from the text: this is a review without a systematic search strategy or primary data, and it relies on model systems that may not fully translate to human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 524 cited sources checked · 0 supported · 0 flagged
None of the sources cited for this claim have been checked yet.
In the paper
“Additionally, mutations detected in the SQSTM1 promoter region are associated with reduced SQSTM1 protein levels in familial ALS-FTD [132,133].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In the most commonly inherited form of ALS and FTD due to mutations in the C9orf72 gene (described below), SQSTM1 accumulates together with ubiquitin in neurons and glia [119–121] as well as muscle fibers [122].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“In fact, individuals with disease-associated C9orf72 mutations display a significantly greater burden of SQSTM1-positive glial inclusions than those with sporadic ALS [82].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
- Not checked yetcites [82] Lorente Pons A, 2020, J Pathol source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In 2011, the seminal discovery of disease-associated expansion mutations within the C9orf72 gene uncovered the most common genetic cause of inherited ALS and FTD, accounting for 23–47% of familial cases and 4–21% of sporadic disease.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“This notion is underscored by the fact that nearly every neurodegenerative disorder is marked by the accumulation of misfolded proteins within or adjacent to affected neurons and glia, in spite of heterogeneous clinical and pathological characteristics among these diseases [68,69].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“SQSTM1 is a major component of neuronal and glial cytoplasmic inclusions that characterize many neurological disorders such as Alzheimer disease and Parkinson disease [114,115].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Although autophagic cargo can be trapped passively within the autophagosome in nonselective autophagy, direct substrate recruitment to phagophores in selective autophagy is mediated by a series of receptor proteins (e.g., SQSTM1/p62 [sequestosome 1], NBR1, AMBRA1) that contain both an LC3-interacting region (LIR) and separate motifs for binding polyubiquitinated proteins [41].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
What the sources say
- Not checked yetcites [41] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Antibodies specific for each dipeptide repeat (DPR) also stain SQSTM1-positive inclusions, including the star-like inclusions unique to C9orf72-related disease, suggesting that DPRs are targeted for clearance by the UPS and/or autophagy [119,169–171] (Figure 1).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“ALS-FTD due to C9orf72 mutations displays TARDBP pathology, consisting of granular neuronal cytoplasmic inclusions, diffuse neuronal cytoplasmic staining, and glial cytoplasmic inclusions rich in TARDBP [120].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
- Not checked yetcites [120] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“On the other hand, loss of endogenous murine C9orf72 results in glial activation, impaired autophagy and toxicity when combined with the C9orf72 expansion mutation [173].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
- Not checked yetcites [173] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 127
- Probably not a substantial claim. 31
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Introduction
What the sources say
- Not checked yetcites [11] source
- Not checked yetcites [12] source
- Not checked yetcites [13] source
- Not checked yetcites [14] source
- Not checked yetcites [15] source
- Not checked yetcites [16] source
- Not checked yetcites [17] source
- Not checked yetcites [18] source
- Not checked yetcites [19] Spaulding HR, 2020, Physiol Rep source
- Not checked yetcites [20] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Macroautophagy, often referred to simply as autophagy, is an evolutionarily conserved eukaryotic pathway for bulk and selective degradation of proteins and organelles [31].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
What the sources say
- Not checked yetcites [31] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“ALS-FTD-associated SQSTM1 mutations frequently affect the UBA and LIR domains involved in autophagy and include both missense and nonsense mutations [123–125].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On the other hand, overexpression of SQSTM1 variants carrying disease-associated mutations in the UBA domain exhibit a PDB-like skeletal disorder [138,139] as well as impaired spatial learning and long-term memory [140].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The initiation step begins with the dissociation of MTOR (mechanistic target of rapamycin kinase) from the PAS, cued by nutrient starvation or treatment with rapamycin or its various derivatives [36,37].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Fusion of the autophagosome and lysosome is mediated by the homotypic fusion and protein sorting (HOPS) complex, whose subunits include VPS11, VPS16, VPS18, VPS33A, VPS39, and VPS41 [45,46].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Additionally, TBK1 amplifies the signaling cascade for mitophagy by phosphorylating OPTN and SQSTM1 (which enhances binding to ubiquitin and LC3) and promoting TBK1 autophosphorylation in a positive-feedback manner [58,59].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Unaffected individuals carry 2–30 repeated stretches of GGGGCC within the first intron of the gene, but patients with C9orf72-associated ALS-FTD harbor several hundred to thousands of repeats [141,142].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Before membrane insertion, the unbound and immature LC3 precursor protein (LC3-I) undergoes proteolytic processing by ATG4, and conjugation to phosphatidylethanolamine through ATG7 and ATG3. The resulting mature, lipidated isoform (LC3-II) is incorporated into the phagophore membrane [41].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
What the sources say
- Not checked yetcites [41] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Knockdown of the SQSTM1 ortholog in zebrafish leads to an ALS-like phenotype consisting of locomotor and motor neuron axonal abnormalities. Overexpression of wild-type human SQSTM1 or application of the autophagy activator rapamycin rescues these phenotypes [137].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
- Not checked yetcites [137] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SQSTM1 mutations are not only a rare cause of ALS-FTD, accounting for ~1-3.5% of cases with or without family history [123–125], but also Paget’s disease of bone (PDB), a chronic and progressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SQSTM1 mutations affecting the UBA domain impair ubiquitin recognition [130], whereas mutations within the LIR domain impact LC3 recognition and substrate delivery to the autophagosomes [84,131].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Global regulation of the myriad effectors and phases of autophagy is overseen by TFEB (transcription factor EB), a basic helix-loop-helix leucine zipper that directs expression of autophagy and lysosomal genes comprising the coordinated lysosomal expression and regulation (CLEAR) network by binding to a conserved promoter motif [47,48].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, SQSTM1-positive inclusions are found in the majority of patients with ALS and FTD, and often overlap with inclusions that stain for ubiquitin and TARDBP/TDP-43 (TAR DNA binding protein), an essential RNA-binding protein integrally connected with ALS-FTD [82,116–118] (Figure 1).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“sqstm1-knockout mice display reduced numbers of osteoclasts as well as cognitive impairment and anxiety, associated with hyperphosphorylated MAPT/tau and neurofibrillary tangles [134–136].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > SQSTM1/p62 in disease
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Next, nucleation of the nascent phagophore is orchestrated by a class III phosphatidylinositol 3-kinase (PtdIns3K) complex containing BECN1, PIK3C3/VPS34, PIK3R4/p150, NRBF2 and either ATG14 or UVRAG [38,39].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Interestingly, degradation of neuronal mitochondria can occur in a non-cell autonomous fashion, as demonstrated by the astrocytic engulfment and degradation of mitochondria excreted from retinal ganglion cells [60].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
What the sources say
- Not checked yetcites [60] source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Expansion then occurs through maturation of the extending phagophore membrane guided by the ATG12–ATG5-ATG16L1 complex, catalyzing insertion of MAP1LC3/LC3 (microtubule associated protein 1 light chain 3) into the phagophore membrane [40,41].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Overview of autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“In contrast, deletion of the mouse C9orf72 ortholog leads to splenomegaly, lymphadenopathy, dysregulation of macrophages and microglia, and excess production of inflammatory cytokines [184–187].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In addition, conditioned medium from astrocytes differentiated from patient-derived iPSC lines (two of which harbor C9orf72 expansion mutations) applied to HEK293T cells reduces LC3-II while increasing SQSTM1 levels [181], suggesting non-cell autonomous inhibition of autophagy by astrocytes in ALS.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
- Not checked yetcites [181] Madill M, 2017, Mol Brain source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“TBK1/NAK/T2K (TANK binding kinase 1) is a cytoplasmically-localized homodimeric multidomain protein with an ubiquitin-like domain, a N-terminal serine/threonine kinase domain, and two coiled-coil domains [192].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1
What the sources say
- Not checked yetcites [192] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Paradoxically, however, c9orf72 knockout in mouse (which models the loss of function attributed to the hexanucleotide repeat expansion) enhances autophagy by de-repressing MTOR and, in turn, increasing TFEB nuclear translocation [179,180].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: c9orf72 knockout in mouse models the loss of function attributed to the C9orf72 hexanucleotide repeat expansion.
None of the sources cited for this claim have been checked yet.
In the paper
“While c9orf72 knockout animals exhibit a shortened lifespan [184,185,187], no specific neuronal defects have been identified in these mice.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The C9orf72 protein belongs to the DENN (differentially expressed in normal and neoplastic cells) family [143,144] and binds the GTPases RAB7 and RAB11, which are involved in endosome maturation and recycling [145].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“TBK1 is expressed in all tissues, but at much higher levels in neurons of the hippocampus, cortex and lateral ventricle. Moderate levels of the protein have been detected in the glial cells of the cortex and cerebellum [193].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1
What the sources say
- Not checked yetcites [193] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Deletion of the zebrafish and C. elegans homologs of C9orf72 results in impaired locomotion and motor axon degeneration [182,183], implying that the C9orf72 protein is essential for motor neuron function and survival in these systems.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Together, these findings suggest that C9orf72 assists in the formation of nascent autophagosomes, consistent with the finding of impaired autophagy in murine cortical neurons [148] and human iPSC-derived neurons [154] upon C9orf72 knockdown.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, C9orf72 expansion mutations are associated not only with ALS/FTLD, but also with symptoms reminiscent of Parkinson disease, Alzheimer disease, Huntington disease, and corticobasal syndrome, reinforcing the imperfect connection between clinical and molecular phenotypes and emphasizing the need for molecular diagnostics [155–164].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
- Not checked yetcites [155] Anor CJ, 2015, Neurobiol Aging
- Not checked yetcites [156] source
- Not checked yetcites [157] Cacace R, 2013, Neurobiol Aging source
- Not checked yetcites [158] Harms M, 2013, JAMA Neurol source
- Not checked yetcites [159] Kostić VS, 2014, J Neurol source
- Not checked yetcites [160] Lesage S, 2013, Brain source
- Not checked yetcites [161] source
- Not checked yetcites [162] source
- Not checked yetcites [163] O’Dowd S, 2012, Mov Disord source
- Not checked yetcites [164] Hensman Moss DJ, 2014, Neurology source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“C9orf72 also forms a complex with SMCR8, a guanine nucleotide exchange factor, and WDR41, a WD40 protein essential for targeting the C9orf72-SMCR8-WDR41 complex to lysosomes [146–150]. Here, this complex interacts with RB1CC1-ULK1-ATG13-ATG101, which together are involved in autophagosome formation [149].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“C9orf72 mutations are associated with reduced basal autophagy and enhanced sensitivity to autophagy inhibitors in human iPSC-derived neurons [153,178].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On the other hand, DPR inclusions rarely co-label with TARDBP pathological inclusions and are mainly found in areas of the CNS that are not pathologically affected [171,174–177], arguing against a direct role for DPRs in neurodegeneration.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Further, neurons derived from iPSCs carrying the C9orf72 repeat expansion recapitulate key features of cellular pathology associated with ALS, including hyperexcitability [154,188,189] and decreased viability upon exposure to excitotoxic agents such as glutamate [154,190,191].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > C9orf72 in disease
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“VCP/p97/Cdc48 (valosin containing protein) is involved in a wide range of essential cellular processes, including DNA replication and repair, cell cycle regulation, and protein clearance [238,239].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In vitro, silencing of TBK1 or ALS-related TBK1 variants reduces the recruitment of OPTN and LC3B to damaged mitochondria [212,213], thereby impairing mitophagy and resulting in the accumulation of defective mitochondria (Figure 1).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1 in disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“TBK1 also phosphorylates SMCR8, which forms a complex with C9orf72 and WDR41, thereby enhancing autophagy initiation [148].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1
What the sources say
- Not checked yetcites [148] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In neurons, TBK1 knockdown enhances the accumulation of SQSTM1, which can be rescued by phosphomimetic SMCR8 mutations [148], suggesting that SMCR8 phosphorylation is crucial for TBK1’s effects on autophagy.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1
What the sources say
- Not checked yetcites [148] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“this effect is exacerbated by genetic loss of ATG5, enhancing stress granule accumulation and, ultimately, leading to cell death [235].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [235] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Unexpectedly, however, TBK1 loss of function also prolongs the disease course by reducing neuroinflammation, suggesting that the dual functions of TBK1 in autophagy and inflammation independently and inversely impact ALS pathogenesis.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1 in disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Conversely, rapamycin-mediated activation of autophagy ameliorates these features, suggesting that FUS-positive inclusions are autophagy substrates [235].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [235] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Neuropathological analysis of CNS tissue from ALS patients with TBK1 mutations shows SQSTM1- and TARDBP-positive inclusions in motor neurons and glia [206,210,211], along with reduced TBK1 mRNA and protein, suggesting haploinsufficiency mechanisms [205,206].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1 in disease
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The majority of disease-associated FUS mutations affect the C-terminal nuclear localization signal, resulting in cytosolic mislocalization and aggregation of mutant FUS [232–234].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Tbk1 haploinsufficiency impairs motor neuron autophagy and accelerates clinical phenotypes as well as the accumulation of mutant SOD1 in transgenic ALS mouse models [214,215].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > TBK1 in disease
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“UBQLN2 modulates MTORC1 activity, lysosomal acidification, and, in turn, autophagosome maturation [229–231].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“while also triggering intracellular inclusions [226,227] and motor defects in vitro and in vivo [226].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“UBQLN2 (ubiquilin 2) is an adaptor protein that binds polyubiquitinated substrates via a C-terminal ubiquitin-associated (UBA) domain, and directs them to the UPS for degradation through an N-terminal ubiquitin-like (UBL) domain [218].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [218] Walters KJ, 2004, Biochim Biophys Acta source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In rats, overexpression of ALS mutant UBQLN2 leads to motor neuron loss and accumulation of autophagy substrates such as SQSTM1 and LC3-II [228].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [228] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“OPTN has emerged as a key player in the regulation of various cellular mechanisms, including vesicular trafficking, maintenance of the Golgi, NFKB/NF-κB signaling and immune response [253].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [253] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Transgenic mice expressing mutant CHMP2B develop progressive neurological defects, axonal pathology, early mortality and neuronal loss reminiscent of FTD [270,271].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [270] Clayton EL, 2017, Hum Mol Genet
- Not checked yetcites [271] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“overexpression of CHMP2B mutants leads to the formation of large cytoplasmic vacuoles and increased LC3-II protein levels [266]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [266] Cox LE, 2010, PLoS One source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These mice also develop lysosomal storage pathology characterized by large neuronal aggregates derived from the endosomal system [272], and early microglial proliferation leading to a pro-inflammatory phenotype at later stages [270].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [272] source
- Not checked yetcites [270] Clayton EL, 2017, Hum Mol Genet
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In IBMPFD murine muscle lysates, VCP mutations disrupt autophagosome maturation and fusion with lysosomes, but not the formation of early autophagosome precursors [246,249].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Motor neurons from CHMP2B mutant ALS patients show increased calcium concentrations, reduced ATP availability, downregulation of the MAPK/p38 signaling pathway and impaired autophagy initiation [266].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [266] Cox LE, 2010, PLoS One source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Genetic analyses have uncovered >20 OPTN mutations in ALS patient cohorts, accounting for ~3% of familial disease and ~1% of sporadic disease [258].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [258] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“ESCRT-III is one of the four multiprotein complexes required for multivesicular body formation, and is responsible for the membrane deformation that enables autophagosome initiation and endolysosomal trafficking [263].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [263] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Motor neurons and astrocytes derived from iPSCs carrying pathogenic VCP mutations demonstrate cytoplasmic TARDBP accumulation, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, and oxidative stress, ultimately leading to cell death [252].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [252] Hall CE, 2017, Cell Rep source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“SQSTM1-positive inclusions are also ubiquitin-positive, consistent with a disruption in the UPS [118].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [118] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Although TARDBP is typically absent from neuronal inclusions found in CHMP2B-associated disease, SQSTM1-positive oligodendroglial inclusions are found in the motor cortex of ALS patients with CHMP2B mutations [267].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [267] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Upon mitochondrial damage, OPTN translocates to the surface of mitochondria, an interaction that is stabilized via TBK1-mediated phosphorylation, facilitating the engulfment of mitochondria into phagophores [256].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [256] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“OPTN is an autophagy receptor that binds ubiquitinated cargo (via its UBAN domain) and LC3 (via its LIR domain) [194,254,255], although it can also act independently of target ubiquitination [254].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“the majority of pathogenic OPTN mutations are located in its UBAN domain and may impair ubiquitin binding [259]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
- Not checked yetcites [259] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“CHMP2B downregulation or expression of disease-associated CHMP2B mutants in Drosophila and mammalian cell lines results in aberrant endosomal structures, impaired autophagosome maturation, and cytosolic TARDBP aggregates [264,265,268,269].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“but are also responsible for ~1-2% of familial ALS cases [241–243].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these observations suggest a conserved pattern of autophagy dysfunction in association with VCP mutations, implying a crucial role for VCP in autophagy and the maintenance of protein homeostasis.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Key autophagy factors and disease-causing mutations in ALS > Other ALS-related mutations and their relation to autophagy
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Mutations in TARDBP, which encodes the transactive response DNA binding protein 43 kDa (TDP-43), are the third most common cause of familial autosomal dominant ALS and account for rare cases of sporadic ALS [290–293].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggest that correcting autophagy dysregulation or promoting the autophagic degradation of TARDBP may be of therapeutic benefit in ALS.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“antagonizing the unfolded protein response (UPR) through deletion of XBP1 [335] triggers autophagy and the clearance of SOD1 inclusions, in the process delaying disease onset and improving survival.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [335] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“overexpression of TFEB enhances LC3 expression and prevents cytotoxicity in SOD1G93A-expressing NSC-34 cells [362].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [362] Chen Y, 2015, Am J Transl Res
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“inducing autophagy using novel compounds belonging to the benzoxazine class of molecules, including 10-NCP, enhance TARDBPM337V degradation and extend survival in rodent and human neurons [357].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [357] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“the phosphodiesterase inhibitor ibudilast induces autophagy by promoting TFEB activity, which enhances clearance of TARDBP aggregates and reduces cytotoxicity [360].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [360] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Mutations in the SOD1 gene, which encode the free radical/reactive oxygen species scavenger superoxide dismutase 1 [294,295], represent the second most common cause of familial ALS in Europeans and the most common cause in those of Asian descent [296].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [296] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“embryonic stem cell-derived motor neurons expressing TARDBPN390D show increased levels of the autophagy suppressor, BCL2, and reduced autophagic activity [300].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [300] Huang SL, 2020, Acta Neuropathol Commun source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“suggesting that these chaperones are key suppressors of autophagy and may accentuate TARDBP-related toxicity in ALS [354].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [354] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“TARDBP downregulation promotes TFEB nuclear localization and TFEB target gene expression, but it also reduces DCTN1 (dynactin subunit 1) expression, thereby blocking autolysosome formation and impairing autophagic flux [350].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [350] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“conditional deletion of Atg7 in mouse motor neurons accentuates early ALS pathology but mitigates glial inflammation and early death [336].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [336] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“autophagy helps eliminate synapses during development [377,378]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Newly-formed autophagosomes in neuronal processes undergo retrograde transport to the soma and proximal segments of neurites to fuse with somatodendritic lysosomes for cargo degradation, with maturation and acidification of the autophagosomal lumen developing en passant [370,372,374].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Baseline autophagy in neurons constitutively operates at a highly processive level, such that maturing autophagosomes are rapidly incorporated into autolysosomes, which represent the majority of the autophagic vesicle population after autophagy induction or flux inhibition [379].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
What the sources say
- Not checked yetcites [379] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Axonal autophagy is dependent on specialized enzymatic apparatuses, including the PINK1-PRKN complex for localized mitophagy [24], KIF1A/UNC-104 for autophagosome formation at the synapse [22,25], and the HTT-HAP1 complex and MAPK8IP1/JIP1 for retrograde transport of autophagosomes [23,26].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Basal autophagy in neurons is essential for maintaining long-term neuronal health, since disruption of baseline autophagic activity in vivo causes neurodegeneration and the accumulation of inclusions containing polyubiquitinated proteins [380,381].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“OPTN mutations produce microglial activation and glaucoma [288]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy
What the sources say
- Not checked yetcites [288] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The interplay between autophagy and TARDBP or SOD1 mutations is complex and influences ALS pathogenesis within and between different cell types of the nervous system.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Alternative methods have proven more successful in neurons, however, including selective MTORC1 inhibition via everolimus [385–387], or modulation of MTOR- and AKT-independent pathways with 10-NCP, an N10-substituted derivative of the heterocyclic dye compound and antipsychotic analog phenoxazine [384].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“With increasing age, basal autophagy and the capacity for efficient autophagosome maturation progressively deteriorate in neurons, leading to accumulation of malformed and immature autophagic vesicles, implying reduced proteostatic reserve over time [382].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
What the sources say
- Not checked yetcites [382] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“rapamycin and related MTOR inhibitors, as well as AKT inhibitors, are ineffective inducers of neuronal autophagy [338,384].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Neurons
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy
What the sources say
- Not checked yetcites [149] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“in the setting of the SOD1G93A mutation, loss of TBK1 or pathogenic TBK1 mutations accentuate several pathologic features of ALS (disease onset, muscle denervation) while ameliorating others (inflammation, early death) [214].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Autophagy in the context of ALS
What the sources say
- Not checked yetcites [214] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Mitochondrial compromise and ATP synthase inhibition with oligomycin A stimulate autophagy to a greater extent in astrocytes than in neurons, although both cell types activate autophagy to similar extents in the face of ischemia [400].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [400] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Activation of microglia through genetic, infectious, inflammatory, or physical stimuli, leads to stereotypical changes in their morphology, accompanied by proliferation, migration, and the release of proinflammatory cytokines and chemokines [417–419].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Microglia are macrophage-like cells that comprise 10–15% of the CNS, and mediate diverse functions ranging from innate immunity and phagocytosis to synaptic pruning and the regulation of synaptic activity [416,417].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Autophagy and phagocytosis share key morphological and mechanistic features [428].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [428] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“These differences in autophagy may be due to enhanced phosphorylation of astrocytic SPHK1/SK1 (sphingosine kinase 1) with starvation, whereas benzoxazines activate neuronal (but not astrocytic) SPHK1 to induce autophagy [11].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [11] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In reactive gliosis, a process unique to astrocytes, intact mitochondrial health is essential and is maintained through autophagy, such that astrocyte-specific deletion of Atg7 perturbs the balance of mitochondrial dynamics to favor fission over fusion and thereby reduces oxidative capacity [401].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [401] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“For instance, both pathways rely on vesicular structures to deliver contents to lysosomes for degradation.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [428] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“not only is autophagy responsible for degrading HTT in astrocytes, but it also promotes glutamate transporter expression in these cells [413]”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [413] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“implying that astrocytes are both necessary and sufficient for neurodegeneration in this ALS model.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“these compounds are sufficient to reduce TARDBPM337V-associated toxicity in iPSC-derived astrocytes [357], presumably through autophagy upregulation.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [357] source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In transgenic mice overexpressing mutant SOD1 associated with ALS, astrocytes display more SOD1-positive inclusions than do neurons, and at an earlier stage [414].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [414] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Conditional oligodendrocyte-specific deletion of Atg5 in mice leads to incomplete differentiation, reduced myelination, abnormal myelin compaction, oligodendrocytic death, and shortened life span [444].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [444] Bankston AN, 2019, Glia source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“C9orf72-deficient mice display lysosomal accumulation and a hyperactive immune response characterized by enhanced production of IL1B and IL6 [184,185,187,439],”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“During oligodendroglial precursor (OPC) differentiation, autophagy becomes most active in distal OPC processes, and autophagosomes are trafficked proximally to the soma in a manner similar to neurons [444].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [444] Bankston AN, 2019, Glia source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Consistent with these findings, autophagy activation enhances oligodendrocyte survival and promotes myelination in a rat model of demyelinating disease [448].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [448] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Collectively, these findings reinforce the convergence between inflammation and autophagy in microglia, and their importance for ALS pathogenesis.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“and conditional Atg7 deletion in mouse Schwann cells leads to cytoplasmic swelling, ribosomal accumulation, dysmorphic ER, and dysmyelination [459].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [459] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“but rapamycin fails to enhance recovery [449] despite effective stimulation of autophagy in these cells [449–451].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Paradoxically, suppression of autophagy with NTF3 (neurotrophin 3) disinhibits oligodendrocyte proliferation and promotes motor recovery in a separate model of spinal cord contusion [452].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [452] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, oligodendrocyte autophagy, OPC differentiation, and myelination during development are all regulated by MTOR [445–447].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Additional non-cell autonomous effects are observed with Schwann cell-specific PTEN deletion or EGFR overexpression, which attenuate peripheral nerve autophagy and lead to disorganization of the nascent neuromuscular junction [461].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [461] Zhang SJ, 2019, Biochem Biophys Res Commun source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The positive effect of exercise on autophagy was first noted in 1984, with the observation of autophagosome accumulation after exercise in rat skeletal muscle [482].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [482] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“neurogenic atrophy can be partially mitigated by adrenergic stimulation, which activates autophagy through Atg7 and counteracts denervation-induced inhibition of autophagic flux [474].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [474] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Starvation-related atrophy is also associated with upregulated autophagy, which in turn is controlled by the transcription factor FOXO3 and is independent of MTOR activity [473].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [473] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Conversely, stimulating Schwann cell autophagy with rapamycin promotes myelination and improves peripheral nerve regeneration [465,466].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The discrepancies suggested by these paradoxical findings may indicate that autophagy is required for muscle maintenance and homeostasis, but there is a limit or threshold beyond which autophagy stimulation may exacerbate fiber atrophy.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Furthermore, conditional deletion of Pik3c3 in murine Schwann cells not only results in hypomyelination, but also in non-cell autonomous disruption of neuronal autophagic flux and dysregulated neuronal trafficking of ERBB2 or ERBB3 receptor tyrosine kinases [460].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Glia
What the sources say
- Not checked yetcites [460] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In ALS, skeletal muscle-specific expression of SOD1G93A is associated with atrophy and elevated autophagy [479],”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [479] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Similar effects have been seen in humans and mice after strenuous exercise, interpreted as a response to exercise-related muscle breakdown [482,483].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These discrepant results may be due to effects of the genetic background unique to each disease, resulting in excessive autophagy stimulation in centronuclear myopathy, but insufficient autophagy in DMD.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Conversely, genetic ablation of RUNX1 disinhibits autophagy and worsens atrophy [472].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [472] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“and conditional Atg7 deletion in mouse skeletal muscle leads to atrophy, weakness, and accumulation of unhealthy mitochondria and sarcoplasmic reticulum [477].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [477] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“skeletal muscle denervation causes neurogenic atrophy and may activate autophagy;”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [472] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Aged rats also show elevated basal mitophagy, higher levels of mitophagy proteins, higher TFEB expression and lysosomal markers than young mice;”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [497] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“On the other hand, sarcopenia involves autophagy of muscle structural components, and attenuation of autophagy with PPARGC1A overexpression mitigates sarcopenia [495].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [495] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These negative trials, together with lithium’s narrow therapeutic index, severely limit the therapeutic utility of lithium for ALS (Figure 3).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but the use of rapamycin in ALS is complicated not only by its potential for insufficient induction of neuronal autophagy per se, but also its capacity for modulating multiple MTOR-dependent downstream pathways (Figure 3).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Mouse muscle also shows age-related decline in autophagy machinery (LC3, BECN1, and LAMP2), and these deficiencies are partially mitigated by 8 weeks of treadmill exercise [491].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [491] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Despite early enthusiasm over lithium in patients and mouse models [505,506], five subsequent trials showed no clinical benefit in survival or neuromuscular outcomes for ALS patients [507–511].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, treatment with autophagy modulating drugs runs the risk of incurring intolerable side effects and toxicities, especially when given on a long-term basis that may be required to prevent or delay late-onset neurodegenerative diseases.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“On the one hand, skeletal muscle autophagy declines with aging in Drosophila and can be rescued by FOXO overexpression or constitutive activation of EIF4EBP1 [490].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [490] source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Neither event is affected by rapamycin, suggesting that MTOR is dispensable for this pathway [512].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
What the sources say
- Not checked yetcites [512] source
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fourth, the effectiveness of these compounds must be tested rigorously in model systems that do not depend upon the overexpression of disease-associated proteins, since this approach may inappropriately emphasize strategies that reduce the non-physiological accumulation of exogenous proteins.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
None of the sources cited for this claim have been checked yet.
In the paper
“the drawbacks of chronic rapamcyin therapy – including cytopenias, nephrotoxicity, metabolic syndrome, dermatitis, and pneumonitis [502,503] – are well known.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“amino acid starvation induces autophagy, whereas amino acid provision results in RPS6KB/p70S6K phosphorylation and autophagy suppression [512].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
What the sources say
- Not checked yetcites [512] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Rapamycin has been extensively utilized for transplant rejection prophylaxis and graft-versus-host disease, as well as seizure control and reduction of tumors in tuberous sclerosis complex patients [499–501].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Similarly, lithium has numerous multi-target effects, including depletion of IP3 through IMPase, activating nitric oxide synthase, inhibiting GSK3B, stimulating NMDA receptors and enhancing glutamatergic tone, among many others (middle).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This results in a narrow therapeutic index for lithium, potentially explaining its apparent lack of neuroprotective effects in human trials for neurodegenerative disease to date.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Autophagy induction is not only seen with endurance exercise, but also acute bouts of exercise, and this short-term increase in autophagy appears to require PPARGC1A [488].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [488] source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“These changes are accompanied by reduced adaptive reserve in response to denervation, with impaired autophagy induction and lower levels of mitophagy compared to young rats [496].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [496] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In aged rats, muscle tissues display elevated basal levels of proteolysis, higher expression of autophagy proteins and the accumulation of unfolded protein response elements.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [496] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The array of MTOR-independent methods for stimulating autophagy also includes direct stimulation of AKT and BECN1, activating MAPK8/JNK1 to dissociate BCL2 from (and thereby disinhibit) BECN1, applying the synthetic peptide Tat-Beclin 1, SIRT1-associated starvation, and disrupting nonsense-mediated RNA decay [513–517] (Figure 3).”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For instance, cell and animal models may not faithfully reproduce autophagy regulation in healthy subjects or humans with disease.”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Concluding remarks: remaining questions & therapeutic implications
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Aging is associated with a decline in muscle mass (termed sarcopenia) and mitochondrial function, both of which are associated with dysregulated autophagy [489].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [489] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Supporting this, skeletal muscle from aged rats exhibits lower LC3 expression, suggesting reduced levels of basal autophagy and an overall decreased capacity for autophagy [494].”
§ Autophagy and ALS: mechanistic insights and therapeutic implications > Cell type-specific regulation of autophagy > Skeletal muscle
What the sources say
- Not checked yetcites [494] source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
Findings from animal and cell models of ALS (e.g., mouse, zebrafish, iPSC) are relevant to human ALS pathogenesis.
“These results are consistent with those in animal models, suggesting that the endogenously encoded C9orf72 repeat expansion mutation leads to toxicity by both gain and loss of function mechanisms.”
The authors state this as an assumption.
c9orf72 knockout in mouse models the loss of function attributed to the C9orf72 hexanucleotide repeat expansion.
“Paradoxically, however, c9orf72 knockout in mouse (which models the loss of function attributed to the hexanucleotide repeat expansion) enhances autophagy by de-repressing MTOR and, in turn, increasing TFEB nuclear translocation [179,180].”
The paper relies on this without support.
Autophagy-based therapies can be effective for ALS and related neurodegenerative diseases.
“This review thereby provides a framework not only to guide further investigations of neuronal autophagy but also to refine therapeutic strategies for ALS and related neurodegenerative diseases.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This self-consumptive pathway maintains cellular and organismal integrity in to the context of various developmental events or stressors by breaking down cellular components and organelles for reuse or redistribution.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [85]
In the citing paper
“Chua et al. (85) have shown that autophagy and proteostasis are not only observed in experimental models of fALS, where specific genetic mutations can impair autophagic effectors or generate proteotoxic stress, but may also play a key role in the pathogenesis of sALS.”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
PPARGC1A is described as both suppressing and driving muscle autophagy
MinorFigure 2 labels PPARGC1A a suppressor of muscle autophagy, while the skeletal-muscle section says its overexpression drives autophagy. The figure does not qualify the suppressive effect by context.
“In muscle, specific transcription factors can exert activating (FOXO3) or suppressive (PPARGC1A, RUNX1) effects on autophagy”
“PPARGC1A/PGC1A (PPARG coactivator 1A) overexpression drives non-MTOR-dependent autophagy by increasing TFEB nuclear localization in dystrophin-deficient muscle fibers [19]”
Citations
Cites
2 retracted
Items 201–400 of 526
Shan, X., Chiang, P., Price, D. L., & Wong, P. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003459107 · Cited by 323
PLIC proteins or ubiquilins regulate autophagy‐dependent cell survival during nutrient starvation
N'Diaye, E., Kajihara, K. K., Hsieh, I., Morisaki, H., Debnath, J., & Brown, E. J. (2009) · The EMBO Reports · doi:10.1038/embor.2008.238 · Cited by 323 · cited 1×
“UBQLN2 can also act as an autophagy receptor by directly interacting with LC3 in autophagosomes [219,220].”
BackgroundAutophagy and Microglia: Novel Partners in Neurodegeneration and Aging
Plaza-Zabala, A., Sierra-Torre, V., & Sierra, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030598 · Cited by 323 · cited 1×
“● Phagocytosis: Autophagy and phagocytosis share key morphological and mechanistic features [428].”
BackgroundAlmeida, S., Gascon, E., Tran, H., Chou, H. J., Gendron, T. F., DeGroot, S., Tapper, A. R., Sellier, C., Charlet-Berguerand, N., Karydas, A., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1149-y · Cited by 321
Levine, T. P., Daniels, R. D., Gatta, A. T., Wong, L. H., & Hayes, M. J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts725 · Cited by 321 · cited 1×
“expressed in normal and neoplastic cells) family [143,144] and binds the GTPases RAB7 and RAB11, which are involved in endosome maturation and recycling [145].”
BackgroundTBK1: a new player in ALS linking autophagy and neuroinflammation
Oakes, J. A., Davies, M. C., & Collins, M. O. (2017) · Molecular Brain · doi:10.1186/s13041-017-0287-x · Cited by 319 · cited 3×
“TBK1 mutations were initially described in conditions with prominent neuroinflammatory responses, including two forms of glaucoma [192,202,203] and herpes simplex encephalitis [204].”
BackgroundMatsumoto, G., Shimogori, T., Hattori, N., & Nukina, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv179 · Cited by 317 · cited 4×
“autophosphorylation in a positive-feedback manner [58,59].”
BackgroundInfluentialDurán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316
Deletion of TDP-43 down-regulates Tbc1d1 , a gene linked to obesity, and alters body fat metabolism
Chiang, P., Ling, J. P., Jeong, Y. H., Price, D. L., Aja, S. M., & Wong, P. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002176107 · Cited by 313
Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1436-x · Cited by 312
Rodent Models of Amyotrophic Lateral Sclerosis
Philips, T., & Rothstein, J. D. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0567s69 · Cited by 311
Compartment-Specific Regulation of Autophagy in Primary Neurons
Maday, S., & Holzbaur, E. L. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4401-15.2016 · Cited by 309 · cited 4×
“neurites to fuse with somatodendritic lysosomes for cargo degradation, with maturation and acidification of the autophagosomal lumen developing en passant [370,372,374].”
BackgroundInfluentialDevlin, A., Burr, K., Borooah, S., Foster, J. D., Cleary, E. M., Geti, I., Vallier, L., Shaw, C. E., Chandran, S., & Miles, G. B. (2015) · Nature Communications · doi:10.1038/ncomms6999 · Cited by 308 · cited 1×
“ity [154,188,189] and decreased viability upon exposure to excitotoxic agents such as glutamate [154,190,191].”
BackgroundInduction of Autophagy in Axonal Dystrophy and Degeneration
Wang, Q. J., Ding, Y., Kohtz, S., Mizushima, N., Cristea, I. M., Rout, M. P., Chait, B. T., Zhong, Y., Heintz, N., & Yue, Z. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2261-06.2006 · Cited by 308 · cited 2×
“eliminate synapses during development [377,378], but can also accentuate axon degeneration during excitotoxic stress [375].”
BackgroundC9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
O’Rourke, J. G., Bogdanik, L., Muhammad, A. K. M. G., Gendron, T. F., Kim, K. J., Austin, A., Cady, J., Liu, E. Y., Zarrow, J., Grant, S., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.027 · Cited by 298
C9orf72 in myeloid cells suppresses STING-induced inflammation
McCauley, M. E., O’Rourke, J. G., Yáñez, A., Markman, J. L., Ho, R., Wang, X., Chen, S., Lall, D., Jin, M., Muhammad, A. K. M. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2625-x · Cited by 298 · cited 2×
“C9orf72-deficient mice display lysosomal accumulation and a hyperactive immune response characterized by enhanced production of IL1B and IL6 [184,185,187,439], a phenotype recapitulated by myeloid-specific C9orf72 knockout, indicating the significance of C9orf72 in maintaining physiological immune responses [440].”
BackgroundSullivan, P. M., Zhou, X., Robins, A. M., Paushter, D. H., Kim, D., Smolka, M. B., & Hu, F. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0324-5 · Cited by 295 · cited 1×
“neural tissues manifest the detrimental effects of compromised autophagy [11], but to varying extents [365,366]: SQSTM1 mutations affect muscle, bone, and liver [125,367,368]; C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]; CHMP2B mutations induce oligodendroglial patholo…”
BackgroundCasadio, M., Ciancanelli, M. J., Ou, Y.-H., Lorenzo, L., Klaudel‐Dreszler, M., Pauwels, E., Sancho‐Shimizu, V., de Diego, R. P., Abhyankar, A., Israelsson, E., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111316 · Cited by 292 · cited 1×
“TBK1 mutations were initially described in conditions with prominent neuroinflammatory responses, including two forms of glaucoma [192,202,203] and herpes simplex encephalitis [204].”
BackgroundMature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
Rodriguez, A., Durán, A., Selloum, M., Champy, M.-F., Diez-Guerra, F. J., Flores, J. M., Serrano, M., Auwerx, J., Diaz-Meco, M. T., & Moscat, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.011 · Cited by 290
Wurzer, B., Zaffagnini, G., Fracchiolla, D., Turco, E., Abert, C., Romanov, J., & Martens, S. (2015) · eLife · doi:10.7554/elife.08941 · Cited by 290 · cited 1×
“merization of the SQSTM1 PB1 domain [91].”
p62/SQSTM1 – steering the cell through health and disease
Sánchez‐Martín, P., & Komatsu, M. (2018) · Journal of Cell Science · doi:10.1242/jcs.222836 · Cited by 289 · cited 1×
“(TB) motif, a KEAP1-interacting region (KIR), and a ubiquitin-associated (UBA) domain [85,86].”
BackgroundSQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Rubino, E., Rainero, I., Chiò, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25df · Cited by 286 · cited 8×
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
BackgroundInfluentialJessen, K. R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.023 · Cited by 284
Zhu, G., Wu, C.-J., Zhao, Y., & Ashwell, J. D. (2007) · Current Biology · doi:10.1016/j.cub.2007.07.041 · Cited by 282
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene
Thomas, J. D., Zhang, Y.-J., Wei, Y.-H., Cho, J.-H., Morris, L. E., Wang, H.-Y., & Zheng, X. F. S. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.008 · Cited by 278 · cited 1×
“Additionally, through its interactions with ULK1 and RAB1A, a GTP-binding protein involved in vesicular protein trafficking and MTOR regulation [151,152], C9orf72 promotes autophagy initiation [153].”
BackgroundRole of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle
Vainshtein, A., Tryon, L. D., Pauly, M., & Hood, D. A. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00380.2014 · Cited by 273
Swarup, V., Phaneuf, D., Bareil, C., Robertson, J., Rouleau, G. A., Križ, J., & Julien, J. (2011) · Brain · doi:10.1093/brain/awr159 · Cited by 270
Control of autophagy initiation by phosphoinositide 3‐phosphatase jumpy
Vergne, I., Roberts, E., Elmaoued, R. A., Tosch, V., Delgado, M. A., Proikas‐Cezanne, T., Laporte, J., & Deretic, V. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.159 · Cited by 270 · cited 1×
“ing MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269
Brettschneider, J., Toledo, J. B., Van Deerlin, V. M., Elman, L., McCluskey, L., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039216 · Cited by 268 · cited 1×
“microglial activation that correlates with disease progression [438].”
BackgroundTsvetkov, A. S., Miller, J., Arrasate, M., Wong, J. S., Pleiss, M. A., & Finkbeiner, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004498107 · Cited by 266 · cited 3×
“ods have proven more successful in neurons, however, including selective MTORC1 inhibition via everolimus [385–387], or modulation of MTOR- and AKT-independent pathways with 10-NCP, an N(10)-substituted derivative of the heterocyclic dye compound and antipsychotic analog phenoxazine [384].”
BackgroundTyler, W. A., Gangoli, N., Gokina, P., Kim, H. A., Covey, M., Levison, S. W., & Wood, T. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0234-09.2009 · Cited by 263
Atanasio, A., Decman, V., White, D., Ramos, M., Ikiz, B., Lee, H.-C., Siao, C.-J., Brydges, S., LaRosa, E., Bai, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23204 · Cited by 263 · cited 2×
“C9orf72-deficient mice display lysosomal accumulation and a hyperactive immune response characterized by enhanced production of IL1B and IL6 [184,185,187,439], a phenotype recapitulated by myeloid-specific C9orf72 knockout, indicating the significance of C9orf72 in maintaining physiological immune responses [440].”
BackgroundWiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., & Kunz, W. S. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00008-2 · Cited by 262
TREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis
Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262
Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)
Cox, L. E., Ferraiuolo, L., Goodall, E. F., Heath, P. R., Higginbottom, A., Mortiboys, H., Hollinger, H. C., Hartley, J. A., Brockington, A., Burness, C. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009872 · Cited by 262 · cited 2×
“reduced ATP availability, downregulation of the MAPK/p38 signaling pathway and impaired autophagy initiation [266].”
BackgroundK63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells
Linares, J. F., Durán, Á., Yajima, T., Pasparakis, M., Moscat, J., & Díaz-Meco, M. T. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.020 · Cited by 261
TDP‐43, a neuro‐pathosignature factor, is essential for early mouse embryogenesis
Wu, L., Cheng, W., Hou, S., Yan, Y., Jiang, S., & Shen, C. ‐. J. (2010) · genesis · doi:10.1002/dvg.20584 · Cited by 256
Liu, Z., Chen, P., Gao, H., Gu, Y., Yang, J., Peng, H., Xu, X., Wang, H., Yang, M., Liu, X., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.015 · Cited by 254
Autophagy promotes synapse development in Drosophila
Shen, W., & Ganetzky, B. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200907109 · Cited by 252 · cited 1×
“eliminate synapses during development [377,378], but can also accentuate axon degeneration during excitotoxic stress [375].”
BackgroundWalking the tightrope: proteostasis and neurodegenerative disease
Yerbury, J. J., Ooi, L., Dillin, A. G., Saunders, D. N., Hatters, D. M., Beart, P. M., Cashman, N. R., Wilson, M. R., & Ecroyd, H. W. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13575 · Cited by 251
Motori, E., Puyal, J., Toni, N., Ghanem, A., Angeloni, C., Malaguti, M., Cantelli-Forti, G., Berninger, B., Conzelmann, K.-K., Götz, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.005 · Cited by 249 · cited 1×
“to favor fission over fusion and thereby reduces oxidative capacity [401].”
Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052941 · Cited by 249
Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis
Sasaki, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182160690 · Cited by 249 · cited 1×
“and SQSTM1 [273], suggesting failed or stalled clearance via autophagy.”
Backgroundp62/ SQSTM 1: ‘Jack of all trades’ in health and cancer
Sánchez‐Martín, P., Saito, T., & Komatsu, M. (2018) · FEBS Journal · doi:10.1111/febs.14712 · Cited by 248
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity
Kahan, B., Napoli, K. L., Kelly, P. A., Podbielski, J. M., Hussein, I., Urbauer, D., Katz, S. M., & Buren, C. V. (2000) · Clinical Transplantation · doi:10.1034/j.1399-0012.2000.140201.x · Cited by 246
Zhang, D., Iyer, L. M., He, F., & Aravind, L. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00283 · Cited by 244 · cited 1×
“expressed in normal and neoplastic cells) family [143,144] and binds the GTPases RAB7 and RAB11, which are involved in endosome maturation and recycling [145].”
Backgroundon behalf of the BELNEU CONSORTIUM, Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Engelborghs, S., De Bleecker, J., Ivanoiu, A., Deryck, O., Edbauer, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.159 · Cited by 242 · cited 1×
“SQSTM1- and TARDBP-positive inclusions in motor neurons and glia [206,210,211], along with reduced TBK1 mRNA and protein, suggesting haploinsufficiency mechanisms [205,206].”
BackgroundMutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology
Teyssou, E., Takeda, T., Lebon, V., Boillée, S., Doukouré, B., Bataillon, G., Sazdovitch, V., Cazeneuve, C., Meininger, V., LeGuern, E., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1090-0 · Cited by 241 · cited 1×
“neural tissues manifest the detrimental effects of compromised autophagy [11], but to varying extents [365,366]: SQSTM1 mutations affect muscle, bone, and liver [125,367,368]; C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]; CHMP2B mutations induce oligodendroglial patholo…”
BackgroundGan, B., Xu, P., Nagy, T., Alcaraz, A., Gu, H., & Guan, J. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200604129 · Cited by 239
A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy
Yang, M., Liang, C., Swaminathan, K., Herrlinger, S., Lai, F., Shiekhattar, R., & Chen, J.-F. (2016) · Science Advances · doi:10.1126/sciadv.1601167 · Cited by 238 · cited 1×
“TBK1-dependent effects on autophagy and autophagy receptor proteins are spatially and functionally regulated by interactions with the ULK1 initiation complex [148,150,153,197].”
BackgroundRegulation of autophagy by phosphatidylinositol 3‐phosphate
Burman, C., & Ktistakis, N. T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.011 · Cited by 234
Lindström, V., Gustafsson, G., Sanders, L. H., Howlett, E. H., Sigvardson, J., Kasrayan, A., Ingelsson, M., Bergström, J., & Erlandsson, A. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.009 · Cited by 233
Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1476-2 · Cited by 231
Progressive motor weakness in transgenic mice expressing human TDP-43
Stallings, N. R., Puttaparthi, K., Luther, C. M., Burns, D. K., & Elliott, J. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.017 · Cited by 225 · cited 2×
“the A315T [301,308,319], Q331K [310], M337V [301,310,311,311,320–322], G348C [308] mutations, knock-in mutant TARDBP [300], or tardbp knockouts [323–328] (these models are reviewed in further detail elsewhere [329–334]).”
BackgroundUbiquilin functions in autophagy and is degraded by chaperone-mediated autophagy
Rothenberg, C., Srinivasan, D., Mah, L., Kaushik, S., Peterhoff, C. M., Ugolino, J., Fang, S., Cuervo, A. M., Nixon, R. A., & Monteiro, M. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq231 · Cited by 225 · cited 1×
“UBQLN2 can also act as an autophagy receptor by directly interacting with LC3 in autophagosomes [219,220].”
BackgroundTsai, K., Yang, C.-H., Fang, Y.-H., Cho, K.-H., Chien, W., Wang, W., Wu, T., Lin, C., Fu, W., & Shen, C.-K. J. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092164 · Cited by 225
Lavieu, G., Scarlatti, F., Sala, G., Carpentier, S., Levade, T., Ghidoni, R., Botti, J., & Codogno, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506182200 · Cited by 225
AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm
Pauly, M., Daussin, F., Burelle, Y., Li, T., Godin, R., Fauconnier, J., Koechlin-Ramonatxo, C., Hugon, G., Lacampagne, A., Coisy-Quivy, M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.04.004 · Cited by 225 · cited 1×
“an AMP analog which stimulates AMPK) improves muscle strength and contractility [480,481].”
BackgroundModelling amyotrophic lateral sclerosis: progress and possibilities
Damme, P. V., Robberecht, W., & Bosch, L. V. D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029058 · Cited by 225
Brosius Lutz, A., Chung, W.-S., Sloan, S. A., Carson, G. A., Zhou, L., Lovelett, E., Posada, S., Zuchero, J. B., & Barres, B. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710566114 · Cited by 225
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene
Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., Murakami, T., Takehisa, Y., Ikeda, Y., Kamiya, T., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.045 · Cited by 223 · cited 1×
“Although elevated LC3-II in this context could represent compromised autophagy flux, reduced levels of active/phosphorylated markers of the MTOR pathway [337] suggest”
BackgroundZhu, Q., Jiang, J., Gendron, T. F., McAlonis-Downes, M., Jiang, L., Taylor, A., Diaz Garcia, S., Ghosh Dastidar, S., Rodriguez, M. J., King, P., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0619-5 · Cited by 220
Selvaraj, B. T., Livesey, M. R., Zhao, C., Gregory, J. M., James, O. T., Cleary, E. M., Chouhan, A. K., Gane, A. B., Perkins, E., Dando, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02729-0 · Cited by 214
Papadeas, S. T., Kraig, S. E., O'Banion, C., Lepore, A. C., & Maragakis, N. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103141108 · Cited by 213 · cited 1×
“Supporting the notion of non-cell autonomous contributions to disease, transplantation of SOD1 astrocytes into the spinal cords of wild-type mice induced motor neuron loss [347].”
BackgroundKIF1A/UNC-104 Transports ATG-9 to Regulate Neurodevelopment and Autophagy at Synapses
Stavoe, A. K. H., Kargbo-Hill, S. E., Hall, D. H., & Colón-Ramos, D. A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.06.012 · Cited by 211
Disrupted autophagy after spinal cord injury is associated with ER stress and neuronal cell death
Liu, S., Sarkar, C., Dinizo, M., Faden, A. I., Koh, E. Y., Lipinski, M. M., & Wu, J. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.527 · Cited by 209 · cited 1×
“These observations suggest that oligodendrocyte autophagy may play a necessary but insufficient role in post-injury repair of the spinal cord [453], but excessive autophagy in oligo-”
BackgroundTransgenic Rat Model of Neurodegeneration Caused by Mutation in the TDP Gene
Zhou, H., Huang, C., Chen, H., Wang, D., Landel, C. P., Xia, P. Y., Bowser, R. P., Liu, Y.-J., & Xia, X. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000887 · Cited by 209
Kanazawa, T., Taneike, I., Akaishi, R., Yoshizawa, F., Furuya, N., Fujimura, S., & Kadowaki, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306337200 · Cited by 208 · cited 1×
“sents an alternative strategy for regulating autophagy in an MTOR-independent fashion: amino acid starvation induces autophagy, whereas amino acid provision results in RPS6KB/ p70S6K phosphorylation and autophagy suppression [512].”
BackgroundDegradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system
Wang, X., Fan, H., Ying, Z., Li, B., Wang, H., & Wang, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.055 · Cited by 207 · cited 1×
“Inhibition of MTOR likewise reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS [353,358,359].”
BackgroundThe neuropathology associated with repeat expansions in the C9ORF72 gene
Mackenzie, I. R. A., Frick, P., & Neumann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1232-4 · Cited by 206 · cited 1×
“fuse neuronal cytoplasmic staining, and glial cytoplasmic inclusions rich in TARDBP [120].”
BackgroundCuster, S. K., Neumann, M., Lu, H., Wright, A. C., & Taylor, J. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq050 · Cited by 204 · cited 1×
“Moreover, muscle from IBMPFD patients carrying VCP mutations [246] and transgenic mice expressing VCP mutants [244,248,249] display accumulations of SQSTM1- and LC3-positive autopha-”
BackgroundDynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy
Myeku, N., & Figueiredo-Pereira, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149252 · Cited by 203
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies
Hensman Moss, D. J., Poulter, M., Beck, J., Hehir, J., Polke, J. M., Campbell, T., Adamson, G., Mudanohwo, E., McColgan, P., Haworth, A., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000061 · Cited by 203
Loss of TDP-43 causes age-dependent progressive motor neuron degeneration
Iguchi, Y., Katsuno, M., Niwa, J.-I., Takagi, S., Ishigaki, S., Ikenaka, K., Kawai, K., Watanabe, H., Yamanaka, K., Takahashi, R., et al. (2013) · Brain · doi:10.1093/brain/awt029 · Cited by 202
Guo, X., Sun, X., Hu, D., Wang, Y.-J., Fujioka, H., Vyas, R., Chakrapani, S., Joshi, A. U., Luo, Y., Mochly-Rosen, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12646 · Cited by 200 · cited 1×
“In addition, rapamycin facilitates motor neuron degeneration and rapid disease progression in SOD1 ALS mice [338], and excess mitophagy accelerates neurotoxicity and metabolic compromise in ALS models [363].”
BackgroundBer, I. L. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3849 · Cited by 198
Adverse events associated with mTOR inhibitors
Pallet, N., & Legendre, C. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.752814 · Cited by 198 · cited 1×
“toxicity, metabolic syndrome, dermatitis, and pneumonitis [502,503] – are well known.”
BackgroundThe Autophagy Lysosomal Pathway and Neurodegeneration
Finkbeiner, S. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033993 · Cited by 196
Aggarwal, S. P., Zinman, L., Simpson, E., McKinley, J., Jackson, K. E., Pinto, H., Kaufman, P., Conwit, R. A., Schoenfeld, D., Shefner, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70068-5 · Cited by 195
TDP‐43 loss of function increases TFEB activity and blocks autophagosome–lysosome fusion
Xia, Q., Wang, H., Hao, Z., Fu, C., Hu, Q., Gao, F., Ren, H., Chen, D., Han, J., Ying, Z., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201591998 · Cited by 195
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
Xu, Y.-F., Zhang, Y., Lin, W.-L., Cao, X., Stetler, C. T., Dickson, D. W., Lewis, J. M., & Petrucelli, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-73 · Cited by 189
Distinct roles for motor neuron autophagy early and late in the SOD1 G93A mouse model of ALS
Rudnick, N. D., Griffey, C. J., Guarnieri, P., Gerbino, V., Wang, X., Piersaint, J. A., Tapia, J. C., Rich, M. M., & Maniatis, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704294114 · Cited by 189
Nishihira, Y., Tan, C.-F., Onodera, O., Toyoshima, Y., Yamada, M., Morita, T., Nishizawa, M., Kakita, A., & Takahashi, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0385-z · Cited by 187 · cited 1×
“Furthermore, glial TARDBP inclusions predominantly reside in oligodendrocytes [345,346], and expression of TARDBP in astrocytes exerts cell autonomous toxicity [299].”
BackgroundLoss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling
Ugolino, J., Ji, Y. J., Conchina, K., Chu, J., Nirujogi, R. S., Pandey, A., Brady, N. R., Hamacher-Brady, A., & Wang, J. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006443 · Cited by 185 · cited 1×
“increasing TFEB nuclear translocation [179,180].”
Mackenzie, I. R. A., Ansorge, O., Strong, M., Bilbao, J., Zinman, L., Ang, L.-C., Baker, M., Stewart, H., Eisen, A., Rademakers, R., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0838-7 · Cited by 183
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans
Therrien, M., Rouleau, G. A., Dion, P. A., & Parker, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083450 · Cited by 183 · cited 1×
“[182,183], implying that the C9orf72 protein is essential for”
BackgroundArriola Apelo, S. I., Neuman, J. C., Baar, E. L., Syed, F. A., Cummings, N. E., Brar, H. K., Pumper, C. P., Kimple, M. E., & Lamming, D. W. (2016) · Aging Cell · doi:10.1111/acel.12405 · Cited by 182
Mann, D. M., Rollinson, S., Robinson, A., Bennion Callister, J., Thompson, J. C., Snowden, J. S., Gendron, T., Petrucelli, L., Masuda-Suzukake, M., Hasegawa, M., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-68 · Cited by 182
Hall, C. E., Yao, Z., Choi, M., Tyzack, G. E., Serio, A., Luisier, R., Harley, J., Preza, E., Arber, C., Crisp, S. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.024 · Cited by 179 · cited 1×
“sence of non-cell autonomous mechanisms of neurodegeneration in VCP-related diseases [252].”
BackgroundMutant valosin‐containing protein causes a novel type of frontotemporal dementia
Schröder, R., Watts, G. D. J., Mehta, S. G., Evert, B. O., Broich, P., Fließbach, K., Pauls, K., Hans, V. H., Kimonis, V., & Thal, D. R. (2005) · Annals of Neurology · doi:10.1002/ana.20407 · Cited by 177
Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle
Wang, X., Blagden, C., Fan, J., Nowak, S. J., Taniuchi, I., Littman, D. R., & Burden, S. J. (2005) · Genes & Development · doi:10.1101/gad.1318305 · Cited by 177 · cited 1×
“Conversely, genetic ablation of RUNX1 disinhibits autophagy and worsens atrophy [472].”
BackgroundTang, G., Yue, Z., Tallóczy, Z., Hagemann, T. L., Cho, W., Messing, A., Sulzer, D., & Goldman, J. E. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn042 · Cited by 176 · cited 1×
“Rosenthal fibers and, in turn, proteasomal impairment [399].”
BackgroundLoss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Philtjens, S., Heeman, B., Engelborghs, S., Vandenbulcke, M., De Baets, G., Bäumer, V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002220 · Cited by 174
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective
Horgusluoglu, E., Nudelman, K., Nho, K., & Saykin, A. J. (2017) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32429 · Cited by 174
Shi, G., Shi, J., Liu, K., Liu, N., Wang, Y., Fu, Z., Ding, J., Jia, L., & Yuan, W. (2013) · Glia · doi:10.1002/glia.22451 · Cited by 173 · cited 2×
“Schwann cells Activates [465] Activates [467,468] FIG4 [13] MIR195 [14,15]”
BackgroundSasaki, S., & Iwata, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12314-4 · Cited by 173
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172 · cited 1×
“neural tissues manifest the detrimental effects of compromised autophagy [11], but to varying extents [365,366]: SQSTM1 mutations affect muscle, bone, and liver [125,367,368]; C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]; CHMP2B mutations induce oligodendroglial patholo…”
BackgroundWu, L.-S., Cheng, W.-C., & Shen, C. ‐. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359000 · Cited by 171
Pathological consequences of VCP mutations on human striated muscle
Hubbers, C. U., Clemen, C. S., Kesper, K., Boddrich, A., Hofmann, A., Kamarainen, O., Tolksdorf, K., Stumpf, M., Reichelt, J., Roth, U., et al. (2007) · Brain · doi:10.1093/brain/awl238 · Cited by 170
Caccamo, A., Majumder, S., Deng, J. J., Bai, Y., Thornton, F. B., & Oddo, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031278 · Cited by 169 · cited 1×
“To this end, inducing autophagy with rapamycin reduces TARDBP accumulation and mislocalization in vitro [352] and in vivo [353], whereas inhibiting autophagy with 3-methyladenine impairs TARDBP degradation [352].”
Backgroundvan der Zee, J., Urwin, H., Engelborghs, S., Bruyland, M., Vandenberghe, R., Dermaut, B., De Pooter, T., Peeters, K., Santens, P., De Deyn, P. P., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm309 · Cited by 167
Small GTP-binding proteins and their role in transport
Goud, B., & McCaffrey, M. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90033-u · Cited by 165 · cited 1×
“Additionally, through its interactions with ULK1 and RAB1A, a GTP-binding protein involved in vesicular protein trafficking and MTOR regulation [151,152], C9orf72 promotes autophagy initiation [153].”
BackgroundRegulation of Autophagy by Neuropathological Protein TDP-43
Bose, J. K., Huang, C.-C., & Shen, C.-K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237115 · Cited by 165 · cited 1×
“For example, loss of nuclear TARDBP leads to reduced ATG7 expression [349], and embryonic stem cell-derived motor neurons expressing TARDBP”
BackgroundFry, C. S., Drummond, M. J., Glynn, E. L., Dickinson, J. M., Gundermann, D. M., Timmerman, K. L., Walker, D. K., Volpi, E., & Rasmussen, B. B. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls209 · Cited by 165 · cited 1×
“seen in humans and mice after strenuous exercise, interpreted as a response to exercise-related muscle breakdown [482,483].”
BackgroundAdaptive plasticity of autophagic proteins to denervation in aging skeletal muscle
O'Leary, M. F., Vainshtein, A., Iqbal, S., Ostojic, O., & Hood, D. A. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00240.2012 · Cited by 165 · cited 1×
“These changes are accompanied by reduced adaptive reserve in response to denervation, with impaired autophagy induction and lower levels of mitophagy compared to young rats [496].”
BackgroundFiglia, G., Gerber, D., & Suter, U. (2018) · Glia · doi:10.1002/glia.23273 · Cited by 165
C9orf72 repeat expansions are a rare genetic cause of parkinsonism
Lesage, S., Le Ber, I., Condroyer, C., Broussolle, E., Gabelle, A., Thobois, S., Pasquier, F., Mondon, K., Dion, P. A., Rochefort, D., et al. (2013) · Brain · doi:10.1093/brain/aws357 · Cited by 164
Transgenic mouse models of amyotrophic lateral sclerosis
Julien, J., & Križ, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.006 · Cited by 162
Mizuno, Y., Amari, M., Takatama, M., Aizawa, H., Mihara, B., & Okamoto, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.060 · Cited by 158 · cited 7×
“Not only do astrocytes and neurons harbor extensive morphologic and physiologic differences, but the regulatory pathways coordinating autophagy and the physiologic consequences of autophagy activation in each cell type may also differ considerably, depending on the pharmacologic or pathologic context: ● Adaptive prote…”
BackgroundInfluentialCdc48 and Ufd3, new partners of the ubiquitin protease Ubp3, are required for ribophagy
Ossareh‐Nazari, B., Bonizec, M., Cohen, M. M., Dokudovskaya, S., Delalande, F., Schaeffer‐Reiss, C., DORSSELAER, A. V., & Dargemont, C. (2010) · EMBO Reports · doi:10.1038/embor.2010.74 · Cited by 157
Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running
Jamart, C., Francaux, M., Millet, G. Y., Deldicque, L., Frère, D., & Féasson, L. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00952.2011 · Cited by 157 · cited 9×
“In rats, overexpression of ALS mutant UBQLN2 leads to motor neuron loss and accumulation of autophagy substrates such as SQSTM1 and LC3-II [228].”
InfluentialAsai, T., Tomita, Y., Nakatsuka, S., Hoshida, Y., Myoui, A., Yoshikawa, H., & Aozasa, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02172.x · Cited by 155
Role of chaperone‐mediated autophagy in metabolism
Tasset, I., & Cuervo, A. M. (2016) · FEBS Journal · doi:10.1111/febs.13677 · Cited by 154
Nguyen, L. S., Vautier, M., Allenbach, Y., Zahr, N., Benvéniste, O., Funck‐Brentano, C., & Salem, J. (2019) · Drug Safety · doi:10.1007/s40264-019-00810-9 · Cited by 154
SQSTM1 mutations – Bridging Paget disease of bone and ALS/FTLD
Rea, S. L., Majcher, V., Searle, M. S., & Layfield, R. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.020 · Cited by 152 · cited 2×
“gressive skeletal disorder characterized by disorganized bone turnover [126,127], and inclusion body myositis (IBM) [128].”
BackgroundJamart, C., Naslain, D., Gilson, H., & Francaux, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2013 · Cited by 148 · cited 1×
“plasma insulin, which in turn downregulates AKT and FOXO3 signaling [16,18].”
BackgroundCrystal Structure of the Ubiquitin-associated (UBA) Domain of p62 and Its Interaction with Ubiquitin
Isogai, S., Morimoto, D., Arita, K., Unzai, S., Tenno, T., Hasegawa, J., Sou, Y., Komatsu, M., Tanaka, K., Shirakawa, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259630 · Cited by 144 · cited 1×
“Homodimerization of the UBA domain maintains SQSTM1 in an inactive state by preventing its interaction with ubiquitin [87,88].”
BackgroundCorticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease
Lindquist, S., Duno, M., Batbayli, M., Puschmann, A., Braendgaard, H., Mardosiene, S., Svenstrup, K., Pinborg, L., Vestergaard, K., Hjermind, L., et al. (2013) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01903.x · Cited by 143
p97: The Cell's Molecular Purgatory?
Halawani, D., & Latterich, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.003 · Cited by 143 · cited 1×
“replication and repair, cell cycle regulation, and protein clearance [238,239].”
BackgroundInvolvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice
Ito, Y., Yamada, M., Tanaka, H., Aida, K., Tsuruma, K., Shimazawa, M., Hozumi, I., Inuzuka, T., Takahashi, H., & Hara, H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.013 · Cited by 141
Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases
Corti, O., Blomgren, K., Poletti, A., & Beart, P. M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15002 · Cited by 141
Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
Evans, C. S., & Holzbaur, E. L. (2020) · eLife · doi:10.7554/elife.50260 · Cited by 137
Boivin, M., Pfister, V., Gaucherot, A., Ruffenach, F., Negroni, L., Sellier, C., & Charlet‐Berguerand, N. (2020) · The EMBO Journal · doi:10.15252/embj.2018100574 · Cited by 137 · cited 1×
“acting synergistically to accentuate neurodegeneration [154,172,173].”
Functional Dissection of the TBK1 Molecular Network
Goncalves, A., Bürckstümmer, T., Dixit, E., Scheicher, R., Górna, M. W., Karayel, E., Sugar, C., Stukalov, A., Berg, T., Kralovics, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023971 · Cited by 136
Carter, H. N., Kim, Y., Erlich, A. T., Zarrin‐khat, D., & Hood, D. A. (2018) · The Journal of Physiology · doi:10.1113/jp275998 · Cited by 136 · cited 1×
“Aged rats also show elevated basal mitophagy, higher levels of mitophagy proteins, higher TFEB expression and lysosomal markers than young mice; these changes were reduced with chronic and forced contractile activity induced by implanted stimulators [497].”
BackgroundRole of p62/SQSTM1 in liver physiology and pathogenesis
Manley, S., Williams, J. A., & Ding, W.-X. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213489446 · Cited by 135 · cited 1×
“neural tissues manifest the detrimental effects of compromised autophagy [11], but to varying extents [365,366]: SQSTM1 mutations affect muscle, bone, and liver [125,367,368]; C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]; CHMP2B mutations induce oligodendroglial patholo…”
BackgroundMadill, M., McDonagh, K., Ma, J., Vajda, A., McLoughlin, P., O’Brien, T., Hardiman, O., & Shen, S. (2017) · Molecular Brain · doi:10.1186/s13041-017-0300-4 · Cited by 134 · cited 2×
“In addition, conditioned medium from astrocytes differentiated from patient-derived iPSC lines (two of which harbor C9orf72 expansion mutations) applied to HEK293T cells reduces LC3II while increasing SQSTM1 levels [181], suggesting non-cell autonomous inhibition of autophagy by astrocytes in ALS.”
BackgroundThe endocytic pathway in microglia during health, aging and Alzheimer’s disease
Solé-Domènech, S., Cruz, D. L., Capetillo-Zarate, E., & Maxfield, F. R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.002 · Cited by 133 · cited 1×
“nections between phagocytosis and autophagy, microglial phagocytosis of Aβ deposits in Alzheimer disease models [430,431] requires the autophagy-related factors BECN1, ATG7 and LC3 [432,433].”
Background(2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70037-1 · Cited by 132
Mitochondrial quality control by the Pink1/Parkin system
Rüb, C., Wilkening, A., & Voos, W. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2485-8 · Cited by 132 · cited 3×
“nates mitochondrial surface proteins [24].”
BackgroundKuusisto, E., Suuronen, T., & Salminen, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4107 · Cited by 131 · cited 1×
“ders such as Alzheimer disease and Parkinson disease [114,115].”
BackgroundDaroszewska, A., van 't Hof, R. J., Rojas, J. A., Layfield, R., Landao-Basonga, E., Rose, L., Rose, K., & Ralston, S. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr172 · Cited by 131 · cited 1×
“On the other hand, overexpression of SQSTM1 variants carrying disease-associated mutations in the UBA domain exhibit a PDB-like skeletal disorder [138,139] as well as impaired spatial learning and long-term memory [140].”
BackgroundSudria-Lopez, E., Koppers, M., de Wit, M., van der Meer, C., Westeneng, H.-J., Zundel, C. A. C., Youssef, S. A., Harkema, L., de Bruin, A., Veldink, J. H., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1581-x · Cited by 130 · cited 2×
“C9orf72-deficient mice display lysosomal accumulation and a hyperactive immune response characterized by enhanced production of IL1B and IL6 [184,185,187,439], a phenotype recapitulated by myeloid-specific C9orf72 knockout, indicating the significance of C9orf72 in maintaining physiological immune responses [440].”
BackgroundCerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130 · cited 1×
“[422], presumably due to increased CNS microglia or their activation, as suggested by positron emission tomography”
BackgroundMandrioli, J., D’Amico, R., Zucchi, E., Gessani, A., Fini, N., Fasano, A., Caponnetto, C., Chiò, A., Dalla Bella, E., Lunetta, C., et al. (2018) · Medicine · doi:10.1097/md.0000000000011119 · Cited by 128
Kurihara, N., Hiruma, Y., Zhou, H., Subler, M. A., Dempster, D. W., Singer, F. R., Reddy, S. V., Gruber, H. E., Windle, J. J., & Roodman, G. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28267 · Cited by 127 · cited 1×
“On the other hand, overexpression of SQSTM1 variants carrying disease-associated mutations in the UBA domain exhibit a PDB-like skeletal disorder [138,139] as well as impaired spatial learning and long-term memory [140].”
BackgroundRyu, H.-H., Jun, M.-H., Min, K.-J., Jang, D.-J., Lee, Y.-S., Kim, H. K., & Lee, J.-A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.026 · Cited by 125 · cited 2×
“Conversely, rapamycin-mediated activation of autophagy ameliorates these features, suggesting that FUS-positive inclusions are autophagy substrates [235].”
BackgroundNon-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43
Uchida, A., Sasaguri, H., Kimura, N., Tajiri, M., Ohkubo, T., Ono, F., Sakaue, F., Kanai, K., Hirai, T., Sano, T., et al. (2012) · Brain · doi:10.1093/brain/awr348 · Cited by 125
Troakes, C., Maekawa, S., Wijesekera, L., Rogelj, B., Siklós, L., Bell, C., Smith, B., Newhouse, S., Vance, C., Johnson, L., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2011.01286.x · Cited by 124
Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification
Şentürk, M., Lin, G., Zuo, Z., Mao, D., Watson, E., Mikos, A. G., & Bellen, H. J. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0281-x · Cited by 124
Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade
Linares, J. F., Durán, Á., Reina‐Campos, M., Aza‐Blanc, P., Campos, A. R., Moscat, J., & Díaz-Meco, M. T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.045 · Cited by 123
Rea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123 · cited 1×
“tin recognition [130], whereas mutations within the LIR domain impact LC3 recognition and substrate delivery to”
BackgroundTripathi, P., Rodriguez-Muela, N., Klim, J. R., de Boer, A. S., Agrawal, S., Sandoe, J., Lopes, C. S., Ogliari, K. S., Williams, L. A., Shear, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.008 · Cited by 123
Environment matters: microglia function and dysfunction in a changing world
Hanamsagar, R., & Bilbo, S. D. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.10.007 · Cited by 122 · cited 1×
“pruning and the regulation of synaptic activity [416,417].”
BackgroundJamart, C., Benoit, N., Raymackers, J.-M., Kim, H. J., Kim, C. K., & Francaux, M. (2012) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2287-3 · Cited by 121 · cited 2×
“Similarly, vastus lateralis biopsies taken from human runners after a 200-kilometer race showed increased transcription of autophagy factors ATG4B, ATG12, GABARAPL1, LC3B, CSTL (cathepsin L), BNIP3, and BNIP3L [487], which may be an adaptive response to muscle injury related to long-distance running.”
BackgroundSasaki, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d44992 · Cited by 121
Schwann cell autophagy counteracts the onset and chronification of neuropathic pain
Marinelli, S., Nazio, F., Tinari, A., Ciarlo, L., D'Amelio, M., Pieroni, L., Vacca, V., Urbani, A., Cecconi, F., Malorni, W., et al. (2014) · Pain · doi:10.1016/j.pain.2013.09.013 · Cited by 119 · cited 1×
“Conversely, stimulating Schwann cell autophagy with rapamycin promotes myelination and improves peripheral nerve regeneration [465,466].”
BackgroundHirano, A. (1996) · Neurology · doi:10.1212/wnl.47.4_suppl_2.63s · Cited by 119
ALS/FTLD: experimental models and reality
Tan, R. H., Ke, Y. D., Ittner, L. M., & Halliday, G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1666-6 · Cited by 119
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118 · cited 1×
“In keeping with this, Tbk1 deletion disrupts the migration of T-cells [216] that may exert antiinflammatory effects in ALS models [192,217].”
BackgroundLysosomal calcium regulates autophagy
Medina, D. L., & Ballabio, A. (2015) · Autophagy · doi:10.1080/15548627.2015.1047130 · Cited by 117
Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
Forloni, G., Artuso, V., Vitola, P. L., & Balducci, C. (2016) · Movement Disorders · doi:10.1002/mds.26624 · Cited by 116 · cited 1×
“erate the atrophy of denervated muscle [71,364].”
Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice
Ghazi-Noori, S., Froud, K. E., Mizielinska, S., Powell, C., Smidak, M., Fernandez de Marco, M., O’Malley, C., Farmer, M., Parkinson, N., Fisher, E. M. C., et al. (2012) · Brain · doi:10.1093/brain/aws006 · Cited by 115 · cited 19×
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
BackgroundInfluentialSynergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43
Urushitani, M., Sato, T., Bamba, H., Hisa, Y., & Tooyama, I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22243 · Cited by 114 · cited 1×
“Inhibition of MTOR likewise reduces TARDBP aggregation and toxicity in multiple cell and animal models of ALS [353,358,359].”
BackgroundMahoney, C. J., Downey, L. E., Ridgway, G. R., Beck, J., Clegg, S., Blair, M., Finnegan, S., Leung, K. K., Yeatman, T., Golden, H., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt144 · Cited by 114
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114 · cited 1×
“neural tissues manifest the detrimental effects of compromised autophagy [11], but to varying extents [365,366]: SQSTM1 mutations affect muscle, bone, and liver [125,367,368]; C9orf72 deficiency leads to lymphocytic inflammation, lymphadenopathy, and splenomegaly [149]; CHMP2B mutations induce oligodendroglial patholo…”
BackgroundAutophagy is essential for oligodendrocyte differentiation, survival, and proper myelination
Bankston, A. N., Forston, M. D., Howard, R. M., Andres, K. R., Smith, A. E., Ohri, S. S., Bates, M. L., Bunge, M. B., & Whittemore, S. R. (2019) · Glia · doi:10.1002/glia.23646 · Cited by 112 · cited 2×
“somes are trafficked proximally to the soma in a manner similar to neurons [444].”
BackgroundAutophagy and amyotrophic lateral sclerosis: The multiple roles of lithium
Fornai, F., Longone, P., Ferrucci, M., Lenzi, P., Isidoro, C., Ruggieri, S., & Paparelli, A. (2008) · Autophagy · doi:10.4161/auto.5923 · Cited by 111 · cited 1×
“Despite early enthusiasm over lithium in patients and mouse models [505,506], five subsequent trials showed no clin-”
BackgroundZhang, H., Tan, C.-F., Mori, F., Tanji, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0285-7 · Cited by 111 · cited 1×
“Furthermore, glial TARDBP inclusions predominantly reside in oligodendrocytes [345,346], and expression of TARDBP in astrocytes exerts cell autonomous toxicity [299].”
BackgroundGadad, B. S., Britton, G. B., & Rao, K. S. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110182 · Cited by 110 · cited 1×
“erate the atrophy of denervated muscle [71,364].”
Janssens, J., Wils, H., Kleinberger, G., Joris, G., Cuijt, I., Groote, C. C., Broeckhoven, C. V., & Kumar‐Singh, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8427-5 · Cited by 110
Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle
Møller, A. B., Vendelbo, M. H., Christensen, B., Clasen, B. F., Bak, A. M., Jørgensen, J. O. L., Møller, N., & Jessen, N. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01116.2014 · Cited by 109
Nakashima, H., Nguyen, T., Goins, W. F., & Chiocca, E. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.593871 · Cited by 109
Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats
Huang, C., Tong, J., Bi, F., Zhou, H., & Xia, X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59130 · Cited by 108
Autophagic response to exercise training in skeletal muscle with age
Kim, Y. A., Kim, Y. S., Oh, S. L., Kim, H.-J., & Song, W. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0246-7 · Cited by 108
Gendron, T. F., van Blitterswijk, M., Bieniek, K. F., Daughrity, L. M., Jiang, J., Rush, B. K., Pedraza, O., Lucas, J. A., Murray, M. E., Desaro, P., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1474-4 · Cited by 106
Marrone, L., Poser, I., Casci, I., Japtok, J., Reinhardt, P., Janosch, A., Andree, C., Lee, H. O., Moebius, C., Koerner, E., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.018 · Cited by 104 · cited 8×
“Intriguingly, FUS may exert a direct influence on autophagy initiation and autophagosome elongation by maintaining expression of factors including RB1CC1 and ATG16L1, which are diminished after CRISPR-mediated knockout of Fus but restored with re-introduction of wild-type FUS in N2A cells [237].”
BackgroundInfluentialCytoplasmic mRNP granules at a glance
Erickson, S. L., & Lykke‐Andersen, J. (2011) · Journal of Cell Science · doi:10.1242/jcs.072140 · Cited by 103 · cited 1×
“initiation factors, translational repressors, and mRNA decay machinery until the stress resolves or is removed [62].”
BackgroundAnimal models of amyotrophic lateral sclerosis: a comparison of model validity
Morrice, J. R., Gregory, C. Y., & Shaw, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241445 · Cited by 103
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Harms, M., Benitez, B. A., Cairns, N., Cooper, B., Cooper, P., Mayo, K., Carrell, D., Faber, K., Williamson, J., Bird, T., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.537 · Cited by 102
Dimerisation of the UBA Domain of p62 Inhibits Ubiquitin Binding and Regulates NF-κB Signalling
Long, J., Garner, T. P., Pandya, M. J., Craven, C. J., Chen, P., Shaw, B., Williamson, M. P., Layfield, R., & Searle, M. S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.11.032 · Cited by 102
A fruitful endeavor: Modeling ALS in the fruit fly
Casci, I., & Pandey, U. B. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.064 · Cited by 102
Gerbino, V., Kaunga, E., Ye, J., Canzio, D., O’Keeffe, S., Rudnick, N. D., Guarnieri, P., Lutz, C. M., & Maniatis, T. (2020) · Neuron · doi:10.1016/j.neuron.2020.03.005 · Cited by 102 · cited 2×
“accumulation of mutant SOD1 in transgenic ALS mouse models [214,215].”
BackgroundCrippa, V., Carra, S., Rusmini, P., Sau, D., Bolzoni, E., Bendotti, C., De Biasi, S., & Poletti, A. (2010) · Autophagy · doi:10.4161/auto.6.7.13042 · Cited by 101 · cited 2×
“HSPB8 overexpression also enhances autophagic clearance of TARDBP via elevations in TFEB, SQSTM1, and LC3 [355,356].”
BackgroundAutophagy as a Potential Target for Sarcopenia: AUTOPHAGY REGULATION IN SARCOPENIA
Fan, J., Kou, X., Jia, S., Yang, X., Yang, Y., & Chen, N. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25260 · Cited by 101 · cited 1×
“mitochondrial function, both of which are associated with dysregulated autophagy [489].”
BackgroundCrippa, V., D’Agostino, V. G., Cristofani, R., Rusmini, P., Cicardi, M. E., Messi, E., Loffredo, R., Pancher, M., Piccolella, M., Galbiati, M., et al. (2016) · Scientific Reports · doi:10.1038/srep22827 · Cited by 101 · cited 2×
“HSPB8 overexpression also enhances autophagic clearance of TARDBP via elevations in TFEB, SQSTM1, and LC3 [355,356].”
BackgroundAutophagic response to strenuous exercise in mouse skeletal muscle fibers
Salminen, A., & Vihko, V. (1984) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02889856 · Cited by 100 · cited 3×
“Skeletal muscle Activates [475] Activates [482] RUNX1 [474]”
BackgroundModification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon
Xu, D., Zhang, T., Xiao, J., Zhu, K., Wei, R., Wu, Z., Meng, H., Li, Y., & Yuan, J. (2015) · Autophagy · doi:10.1080/15548627.2015.1023982 · Cited by 99
Toward an integrative view of Optineurin functions
Kachaner, D., Génin, P., Laplantine, E., & Weil, R. (2012) · Cell Cycle · doi:10.4161/cc.20946 · Cited by 99
Van Mossevelde, S., van der Zee, J., Gijselinck, I., Engelborghs, S., Sieben, A., Van Langenhove, T., De Bleecker, J., Baets, J., Vandenbulcke, M., Van Laere, K., et al. (2016) · Brain · doi:10.1093/brain/awv358 · Cited by 98
Lee, J., Kim, H. R., Quinley, C., Kim, J., González-Navajas, J. M., Xavier, R. J., & Raz, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280065 · Cited by 97 · cited 1×
“Additionally, SQSTM1 directly associates with the proteasome through its PB1 domain [106–108] and is itself a proteasome substrate [109].”
BackgroundTDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Wegorzewska, I., & Baloh, R. H. (2010) · Neurodegenerative Diseases · doi:10.1159/000321547 · Cited by 97
The FReJA consortium, Clayton, E. L., Mizielinska, S., Edgar, J. R., Nielsen, T. T., Marshall, S., Norona, F. E., Robbins, M., Damirji, H., Holm, I. E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1475-3 · Cited by 96 · cited 1×
“by large neuronal aggregates derived from the endosomal system [272], and early microglial proliferation leading to a pro-inflammatory phenotype at later stages [270].”
BackgroundLithium carbonate in amyotrophic lateral sclerosis: Lack of efficacy in a dose-finding trial
Chiò, A., Borghero, G., Calvo, A., Capasso, M., Caponnetto, C., Corbo, M., Giannini, F., Logroscino, G., Mandrioli, J., Marcello, N., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ed9e7c · Cited by 96
Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease
Du, Y., Wooten, M. C., & Wooten, M. W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.015 · Cited by 96 · cited 8×
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
BackgroundInfluentialOptineurin suppression causes neuronal cell death via NF‐κB pathway
Akizuki, M., Yamashita, H., Uemura, K., Maruyama, H., Kawakami, H., Ito, H., & Takahashi, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12326 · Cited by 96 · cited 1×
“In addition, ALS-associated OPTN mutations enhance microglial NFKB1 expression [260], which may accentuate neuronal loss secondary to neuroinflammation [261].”
BackgroundDello Russo, C., Lisi, L., Feinstein, D. L., & Navarra, P. (2013) · Glia · doi:10.1002/glia.22433 · Cited by 96
Chung, M. J., & Suh, Y.-L. (2002) · Ultrastructural Pathology · doi:10.1080/01913120252934260 · Cited by 96
Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro
Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96
Autophagy and Protein Turnover Signaling in Slow-Twitch Muscle during Exercise
PAGANO, A. F., PY, G., BERNARDI, H., CANDAU, R. B., & SANCHEZ, A. M. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000237 · Cited by 96 · cited 1×
“plasma insulin, which in turn downregulates AKT and FOXO3 signaling [16,18].”
BackgroundNeuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 95
Babu, A., Wang, Q., Muralidharan, R., Shanker, M., Munshi, A., & Ramesh, R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500259e · Cited by 94
Fox, J. H., Connor, T., Chopra, V., Dorsey, K., Kama, J. A., Bleckmann, D., Betschart, C., Hoyer, D., Frentzel, S., DiFiglia, M., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-26 · Cited by 94
Gomez-Deza, J., Lee, Y.-B., Troakes, C., Nolan, M., Al-Sarraj, S., Gallo, J.-M., & Shaw, C. E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0218-y · Cited by 93
Kaji, S., Maki, T., Kinoshita, H., Uemura, N., Ayaki, T., Kawamoto, Y., Furuta, T., Urushitani, M., Hasegawa, M., Kinoshita, Y., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.001 · Cited by 93
Roscic, A., Baldo, B., Crochemore, C., Marcellin, D., & Paganetti, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07435.x · Cited by 92
SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles
Bucelli, R. C., Arhzaouy, K., Pestronk, A., Pittman, S. K., Rojas, L., Sue, C. M., Evilä, A., Hackman, P., Udd, B., Harms, M. B., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001864 · Cited by 92
The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis
Atsumi, T. (1981) · Acta Neuropathologica · doi:10.1007/bf00691318 · Cited by 92
Arai, T., Nonaka, T., Hasegawa, M., Akiyama, H., Yoshida, M., Hashizume, Y., Tsuchiya, K., Oda, T., & Ikeda, K. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00216-7 · Cited by 92
Flagged first, then by citations
1 of the 527 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- Laferriere F, 2015, Swiss Med Wkly, 145, w14054
- Le Ber I, 2013, JAMA Neurol, 70, 1403
- Anor CJ, 2015, Neurobiol Aging, 36
- Komine O, 2015, Nagoya J Med Sci, 77, 537
- Arenas A, 2020, J Neurochem
- Clayton EL, 2017, Hum Mol Genet, 26, 873
- Chen Y, 2015, Am J Transl Res, 7, 1574
- Miller RH, 1994, Perspect Dev Neurobiol, 2, 225
- Kulkarni A, 2019, Autophagy.
- Nguyen LS, 2019, Drug Saf, 42, 813
Cited by
Sorted by citations
Autophagy, aging, and age-related neurodegeneration
Palmer, J. E., Wilson, N., Son, S. M., Obrocki, P., Wróbel, L., Rob, M., Takla, M., Korolchuk, V. I., & Rubinsztein, D. C. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.015 · Cited by 277
The role of lysosomes in metabolic and autoimmune diseases
Gros, F., & Muller, S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00692-2 · Cited by 205
DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy
Imberechts, D., Kinnart, I., Wauters, F., Terbeek, J., Manders, L., Wierda, K. D. B., Eggermont, K., Madeiro, R. F., Sue, C. M., Verfaillie, C. M., et al. (2022) · Brain · doi:10.1093/brain/awac313 · Cited by 168
“Mutations in the genes for optineurin and its interactor TBK1 cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.(54) Interestingly, although most patients with PARK7 mutations have typical early-onset PD, some develop ALS and dementia in addition to parkinsonism.”
BackgroundMeng, K., Jia, H., Hou, X., Zhu, Z., Lu, Y., Feng, Y., Feng, J., Xia, Y., Tan, R., Cui, F., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020327 · Cited by 82
“Mitochondrial biogenesis refers to a series of molecular processes of mitochondrial replication, including transcription of nuclear DNA and mitochondrial DNA, protein synthesis, and assembly of respiratory chains, which play an important role in maintaining mitochondrial homeostasis [9].”
µMap proximity labeling in living cells reveals stress granule disassembly mechanisms
Pan, C., Knutson, S. D., Huth, S. W., & MacMillan, D. W. C. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01721-2 · Cited by 80
“Autophagy pathways are responsible for recycling larger cellular components and protein aggregates, and their functional integrity is frequently undermined in diseased cells, plausibly leading to the accumulation of these inclusions 14,66 .”
Background
Metadata
- Authors
- Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J.
- Affiliations
- University of Michigan (US)
- Recherche translationnelle sur les maladies neurologiques, Institut Imagine, UMR-1163 INSERM et Université Paris Descartes, Hôpital Universitaire Necker-Enfants Malades, Paris, France
- Hôpital Necker-Enfants Malades (FR)
- Corresponding author
- Barmada, Sami J.
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2021-05-31
- Volume
- 18
- Issue
- 2
- Pages
- 254-282
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- PMC
- PMC8942428
- OpenAlex
- W3164735937
- Cited by
- 189
- References
- 527
- Citations by year
- 2026: 34 · 2025: 51 · 2024: 46 · 2023: 34 · 2022: 19 · 2021: 5
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Autophagy (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (2R25NS089450-06)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, CHMP2B, dipeptide repeat proteins, PINK1, mTOR, TBK1, TFEB, LC3, VCP, ubiquitin-proteasome system, unfolded protein response, frontotemporal dementia, autophagy-related proteins, therapeutic target
- MeSH terms
- Proteostasis, Amyotrophic Lateral Sclerosis, Autophagy, Humans, Unfolded Protein Response, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review